Zeitschriftenartikel zum Thema „SCD89“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "SCD89" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Berthelot, Laureline, Christina Papista, Thiago T. Maciel, Martine Biarnes-Pelicot, Emilie Tissandie, Pamela H. M. Wang, Houda Tamouza et al. „Transglutaminase is essential for IgA nephropathy development acting through IgA receptors“. Journal of Experimental Medicine 209, Nr. 4 (26.03.2012): 793–806. http://dx.doi.org/10.1084/jem.20112005.
Der volle Inhalt der QuelleWu, Haiting, Xiaoyan Wang, Zhe Yang, Qing Zhao, Yubing Wen, Xuemei Li, Wei Zhang und Ruitong Gao. „Serum Soluble CD89-IgA Complexes Are Elevated in IgA Nephropathy without Immunosuppressant History“. Disease Markers 2020 (16.01.2020): 1–6. http://dx.doi.org/10.1155/2020/8393075.
Der volle Inhalt der Quellevan Zandbergen, Ger, Ralf Westerhuis, Ngaisah Klar Mohamad, Jan G. J. van de Winkel, Mohamed R. Daha und Cees van Kooten. „Crosslinking of the Human Fc Receptor for IgA (FcαRI/CD89) Triggers FcR γ-Chain-Dependent Shedding of Soluble CD89“. Journal of Immunology 163, Nr. 11 (01.12.1999): 5806–12. http://dx.doi.org/10.4049/jimmunol.163.11.5806.
Der volle Inhalt der QuelleDi Leo, Vincenzo, Patrick J. Gleeson, Fabio Sallustio, Carine Bounaix, Jennifer Da Silva, Gesualdo Loreto, Sanae Ben Mkaddem und Renato C. Monteiro. „Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model“. Journal of Personalized Medicine 11, Nr. 4 (16.04.2021): 309. http://dx.doi.org/10.3390/jpm11040309.
Der volle Inhalt der QuelleEsteve Cols, Clara, Freddzia-Amanda Graterol Torres, Bibiana Quirant Sánchez, Helena Marco Rusiñol, Maruja Isabel Navarro Díaz, Jordi Ara del Rey und Eva Mª Martínez Cáceres. „Immunological Pattern in IgA Nephropathy“. International Journal of Molecular Sciences 21, Nr. 4 (18.02.2020): 1389. http://dx.doi.org/10.3390/ijms21041389.
Der volle Inhalt der QuelleZych, Michał, Aleksander Roszczyk, Filip Dąbrowski, Monika Kniotek und Radosław Zagożdżon. „Soluble Forms of Immune Checkpoints and Their Ligands as Potential Biomarkers in the Diagnosis of Recurrent Pregnancy Loss—A Preliminary Study“. International Journal of Molecular Sciences 25, Nr. 1 (29.12.2023): 499. http://dx.doi.org/10.3390/ijms25010499.
Der volle Inhalt der QuelleLiu, Chao, Xiaohui Li, Aijie Li, Wenxue Zou, Rui Huang, Xiaoyu Hu, Jinming Yu, Xiaoling Zhang und Jinbo Yue. „Concurrent Chemoradiotherapy Increases the Levels of Soluble Immune Checkpoint Proteins in Patients with Locally Advanced Cervical Cancer“. Journal of Immunology Research 2022 (04.04.2022): 1–8. http://dx.doi.org/10.1155/2022/9621466.
Der volle Inhalt der QuelleOdagiri, Naoshi, Hoang Hai, Le Thi Thanh Thuy, Minh Phuong Dong, Maito Suoh, Kohei Kotani, Atsushi Hagihara et al. „Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial Chemoembolization“. Cancers 12, Nr. 8 (24.07.2020): 2045. http://dx.doi.org/10.3390/cancers12082045.
Der volle Inhalt der QuelleKAKOULIDOU, M., X. WANG, X. ZHAO, R. PIRSKANEN und A. LEFVERT. „Soluble costimulatory factors sCD28, sCD80, sCD86 and sCD152 in relation to other markers of immune activation in patients with myasthenia gravis“. Journal of Neuroimmunology 185, Nr. 1-2 (April 2007): 150–61. http://dx.doi.org/10.1016/j.jneuroim.2007.01.007.
Der volle Inhalt der QuelleLin, Wei. „sCD83 alleviates experimental autoimmune uveitis through disrupting the regulation of Rab1a/LRRK2 on F-actin rearrangements“. Journal of Immunology 202, Nr. 1_Supplement (01.05.2019): 116.2. http://dx.doi.org/10.4049/jimmunol.202.supp.116.2.
Der volle Inhalt der QuelleZelek, Wioleta M., Lewis M. Watkins, Owain W. Howell, Rhian Evans, Sam Loveless, Neil P. Robertson, Marijke Beenes, Loek Willems, Ricardo Brandwijk und B. Paul Morgan. „Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59“. Multiple Sclerosis Journal 25, Nr. 4 (09.02.2018): 523–31. http://dx.doi.org/10.1177/1352458518758927.
Der volle Inhalt der QuelleKang, Seon Mee, Jun Choul Lee und Bon Jeong Ku. „Changes in Soluble Serum CD81 Concentration during an Oral Glucose Tolerance Test in Patients with Diabetes Mellitus and Individuals with Normal Glucose Tolerance“. Diagnostics 13, Nr. 23 (21.11.2023): 3500. http://dx.doi.org/10.3390/diagnostics13233500.
Der volle Inhalt der QuelleLiu, Shen, Chaoqun Huang, Dawei Li, Weihua Ren, Haoxing Zhang, Meiyan Qi, Xin Li und Long Yu. „Molecular cloning and expression analysis of a new gene for short-chain dehydrogenase/reductase 9.“ Acta Biochimica Polonica 54, Nr. 1 (20.02.2007): 213–18. http://dx.doi.org/10.18388/abp.2007_3289.
Der volle Inhalt der QuelleEinenkel, Rebekka, Katrin Regina Helene Packhäuser, Jens Ehrhardt, Anne Tüngler, Marek Zygmunt und Damián Oscar Muzzio. „CD83 is locally regulated and differentially expressed in disturbed murine pregnancy“. Reproduction 158, Nr. 4 (Oktober 2019): 323–33. http://dx.doi.org/10.1530/rep-19-0171.
Der volle Inhalt der QuelleLinker-Israeli, M., S. Hyun, T. Ozeri-Chen, D. J. Wallace, K. Banks und J. R. Klinenberg. „Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus.“ Journal of Immunology 152, Nr. 6 (15.03.1994): 3158–67. http://dx.doi.org/10.4049/jimmunol.152.6.3158.
Der volle Inhalt der QuelleGong, Xingyu, Tianyi Ma, Qiaoya Zhang, Yanhong Wang, Chengchuang Song, Min Lai, Chunlei Zhang, Xingtang Fang und Xi Chen. „Porcine Reproductive and Respiratory Syndrome Virus Modulates the Switch of Macrophage Polarization from M1 to M2 by Upregulating MoDC-Released sCD83“. Viruses 15, Nr. 3 (17.03.2023): 773. http://dx.doi.org/10.3390/v15030773.
Der volle Inhalt der QuelleIshibashi, Mariko, Ryosuke Kinoshita, Koiti Inokuchi, Hiroshi Handa, Makoto Sasaki, Norio Komatsu, Yoichi Imai et al. „Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression“. Blood 134, Supplement_1 (13.11.2019): 4361. http://dx.doi.org/10.1182/blood-2019-124635.
Der volle Inhalt der QuelleMuñiz, Carmen, Lourdes Martín-Martín, Antonio López, Blanca Sánchez-González, Antonio Salar, Julia Almeida, Juan-Manuel Sancho et al. „Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome“. Blood 123, Nr. 12 (20.03.2014): 1864–69. http://dx.doi.org/10.1182/blood-2013-11-537993.
Der volle Inhalt der QuelleHo, AD, M. Grossman, L. Trumper, A. Pezzutto, H. Pralle, S. Boedewadt-Radzun, U. Papendick, B. God, T. Zwingers und W. Hunstein. „Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia“. Blood 75, Nr. 5 (01.03.1990): 1119–24. http://dx.doi.org/10.1182/blood.v75.5.1119.bloodjournal7551119.
Der volle Inhalt der QuelleHo, AD, M. Grossman, L. Trumper, A. Pezzutto, H. Pralle, S. Boedewadt-Radzun, U. Papendick, B. God, T. Zwingers und W. Hunstein. „Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia“. Blood 75, Nr. 5 (01.03.1990): 1119–24. http://dx.doi.org/10.1182/blood.v75.5.1119.1119.
Der volle Inhalt der QuelleLundell, Anna-Carin, Kerstin Andersson, Elisabet Josefsson, Alexander Steinkasserer und Anna Rudin. „Soluble CD14 and CD83 from Human Neonatal Antigen-Presenting Cells Are Inducible by Commensal Bacteria and Suppress Allergen-Induced Human Neonatal Th2 Differentiation“. Infection and Immunity 75, Nr. 8 (25.05.2007): 4097–104. http://dx.doi.org/10.1128/iai.01744-06.
Der volle Inhalt der QuelleKogure, T., T. Itoh, Y. Shimada, T. Shintani, H. Ochiai und K. Terasawa. „Detection of serum soluble markers of immune activation in rheumatoid arthritis“. Mediators of Inflammation 5, Nr. 4 (1996): 262–65. http://dx.doi.org/10.1155/s0962935196000373.
Der volle Inhalt der QuelleOlszewski, Jurek, Wiesław Chudzik, Kazimierz Wiśniewski, Jarosław Miłonski und Robert Matyja. „An Assessment of Concentrations of Soluble CD4 and CD8 Receptors in Serum before and after Surgical Treatment in Patients with Chronic Maxillary Sinusitis“. American Journal of Rhinology 17, Nr. 3 (Mai 2003): 123–26. http://dx.doi.org/10.1177/194589240301700301.
Der volle Inhalt der QuellePeckert-Maier, Katrin, Dmytro Royzman, Pia Langguth, Anita Marosan, Astrid Strack, Atefeh Sadeghi Shermeh, Alexander Steinkasserer, Elisabeth Zinser und Andreas B. Wild. „Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation“. International Journal of Molecular Sciences 23, Nr. 2 (10.01.2022): 732. http://dx.doi.org/10.3390/ijms23020732.
Der volle Inhalt der QuelleKubysheva, Nailya, Larisa Postnikova, Svetlana Soodaeva, Viкtor Novikov, Tatyana Eliseeva, Ildar Batyrshin, Timur Li, Igor Klimanov und Alexander Chuchalin. „Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients“. Disease Markers 2017 (2017): 1–9. http://dx.doi.org/10.1155/2017/8216723.
Der volle Inhalt der QuelleYin, Xin-Ke, Chao Wang, Li-Li Feng, Shao-Mei Bai, Wei-Xing Feng, Neng-Tai Ouyang, Zhong-Hua Chu, Xin-Juan Fan und Qi-Yuan Qin. „Expression Pattern and Prognostic Value of CTLA-4, CD86, and Tumor-Infiltrating Lymphocytes in Rectal Cancer after Neoadjuvant Chemo(radio)therapy“. Cancers 14, Nr. 22 (14.11.2022): 5573. http://dx.doi.org/10.3390/cancers14225573.
Der volle Inhalt der QuelleMoretti, Edgardo, Beatriz Basso, Liliana Cervetta, Ana Brigada und Gustavo Barbieri. „Patterns of Cytokines and Soluble Cellular Receptors in the Sera of Children with Acute Chagas' Disease“. Clinical and Vaccine Immunology 9, Nr. 6 (November 2002): 1324–27. http://dx.doi.org/10.1128/cdli.9.6.1324-1327.2002.
Der volle Inhalt der QuelleJiang, Chun-Xuan. „THE PRIME PRINCIPLE IN CLUSTERS AND NANOSTRUCTURES“. Algebras Groups and Geometries 39, Nr. 2 (01.12.2023): 189–95. http://dx.doi.org/10.29083/agg.39.02.2023/sc189.
Der volle Inhalt der QuelleHo, AD, M. Maruyama, A. Maghazachi, JR Mason, S. Gluck und RE Corringham. „Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation“. Blood 84, Nr. 10 (15.11.1994): 3550–57. http://dx.doi.org/10.1182/blood.v84.10.3550.3550.
Der volle Inhalt der QuelleHo, AD, M. Maruyama, A. Maghazachi, JR Mason, S. Gluck und RE Corringham. „Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation“. Blood 84, Nr. 10 (15.11.1994): 3550–57. http://dx.doi.org/10.1182/blood.v84.10.3550.bloodjournal84103550.
Der volle Inhalt der QuelleHo, AD, R. Haas, G. Wulf, W. Knauf, R. Ehrhardt, B. Heilig, M. Korbling, G. Schulz und W. Hunstein. „Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma“. Blood 75, Nr. 1 (01.01.1990): 203–12. http://dx.doi.org/10.1182/blood.v75.1.203.203.
Der volle Inhalt der QuelleHo, AD, R. Haas, G. Wulf, W. Knauf, R. Ehrhardt, B. Heilig, M. Korbling, G. Schulz und W. Hunstein. „Activation of lymphocytes induced by recombinant human granulocyte- macrophage colony-stimulating factor in patients with malignant lymphoma“. Blood 75, Nr. 1 (01.01.1990): 203–12. http://dx.doi.org/10.1182/blood.v75.1.203.bloodjournal751203.
Der volle Inhalt der QuellePutz, D., U. Barnas, A. Luger, G. Mayer, W. Woloszczuk und H. Graf. „Biocompatibility of High-Flux Membranes“. International Journal of Artificial Organs 15, Nr. 8 (August 1992): 456–60. http://dx.doi.org/10.1177/039139889201500802.
Der volle Inhalt der QuelleHamed, Nahla, Nahla Farahat, Manal El Sorady, Dalia Nafee und Sherine Barakat. „Clinical significance of sCD86 levels in patients with acute myelogenous leukemia“. Alexandria Journal of Medicine 47, Nr. 1 (01.03.2011): 25–30. http://dx.doi.org/10.1016/j.ajme.2011.04.002.
Der volle Inhalt der QuelleNascimento, Catarina, Andreia Gameiro, Jorge Correia, João Ferreira und Fernando Ferreira. „The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications“. Cells 11, Nr. 16 (18.08.2022): 2578. http://dx.doi.org/10.3390/cells11162578.
Der volle Inhalt der QuelleKashchenko, Mikhail. „INTERPRETATION OF THE MECHANISM OF THE INFLUENCE OF π0- MESONS ON THE PROCESS OF ATTRACTION OF NUCLEI“. Hadronic Journal 47, Nr. 1 (01.03.2024): 89–94. http://dx.doi.org/10.29083/hj.47.01.2024/sc89.
Der volle Inhalt der QuelleDíaz García, Elena, Sara García-Tovar, Enrique Alfaro, Ester Zamarrón, Alberto Mangas, Raúl Galera, José Juan Ruíz Hernández et al. „Role of CD39 in COVID-19 Severity: Dysregulation of Purinergic Signaling and Thromboinflammation“. IBJ Plus 1, s5 (03.06.2022): 1. http://dx.doi.org/10.24217/2531-0151.22v1s5.00001.
Der volle Inhalt der QuelleBarlan, Işil B., M. M. Başaran, M. Bakir, F. Tükenmez und Nural Bekiroğlu. „Serum TNF-α, sCD8 and sIL-2R levels in childhood tuberculosis“. Infection 23, Nr. 4 (Juli 1995): 237–39. http://dx.doi.org/10.1007/bf01781205.
Der volle Inhalt der QuellePujalte, J. M. „Présence pulmonaire de sCD87 au cours du syndrome de détresse respiratoire aiguë (SDRA)“. Revue des Maladies Respiratoires 21, Nr. 6 (Dezember 2004): 1212. http://dx.doi.org/10.1016/s0761-8425(04)71619-8.
Der volle Inhalt der QuelleSpathas, Nikolaos, Anna C. Goussia, Georgia-Angeliki Koliou, Helen Gogas, Flora Zagouri, Anna Batistatou, Antonia V. Charchanti et al. „Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study“. Cancers 14, Nr. 22 (16.11.2022): 5635. http://dx.doi.org/10.3390/cancers14225635.
Der volle Inhalt der QuelleOzkorucu, Duygu, Nuran Cetin, Nadide Melike Sav und Bilal Yildiz. „Urine and serum ghrelin, sCD80 and sCTLA-4 levels in doxorubicin-induced experimental nephrotic syndrome“. International Urology and Nephrology 48, Nr. 7 (27.02.2016): 1187–96. http://dx.doi.org/10.1007/s11255-016-1249-4.
Der volle Inhalt der QuelleSanders, David E., Mark S. Stave, Leslie S. Perkins und Andrew E. DePristo. „SCT89: a computer code for atomic and molecular scattering from clean and adsorbate covered surfaces“. Computer Physics Communications 70, Nr. 3 (Juli 1992): 579–608. http://dx.doi.org/10.1016/0010-4655(92)90118-i.
Der volle Inhalt der QuelleDe Rie, MA, IM Zonneveld, L. Witkamp, RA Van Lier, TA Out und JD Bos. „Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1.“ Acta Dermato-Venereologica 76, Nr. 5 (01.09.1996): 357–60. http://dx.doi.org/10.2340/0001555576357360.
Der volle Inhalt der QuelleKuryliszyn-Moskal, A., K. Bemacka und O. Bielecka. „Soluble CD4 (sCD4), CD8 (sCD8) and cytokine levels in rheumatoid arthritis complicated by vasculitis“. Immunology Letters 56 (Mai 1997): 321. http://dx.doi.org/10.1016/s0165-2478(97)86296-7.
Der volle Inhalt der QuelleKuryliszyn-Moskal, A. „Soluble CD4 (sCD4), CD8 (sCD8) and cytokine levels in rheumatoid arthritis complicated by vasculitis“. Immunology Letters 56, Nr. 1-3 (Mai 1997): 321. http://dx.doi.org/10.1016/s0165-2478(97)88134-5.
Der volle Inhalt der QuelleBrasoveanu, L. I., E. Fonsatti, A. Visintin, M. Pavlovic, I. Cattarossi, F. Colizzi, A. Gasparollo et al. „Melanoma cells constitutively release an anchor-positive soluble protectin (sCD59) that retains functional activities in complement-mediated cytotoxicity“. Melanoma Research 7, Supplement 1 (Juni 1997): S10. http://dx.doi.org/10.1097/00008390-199706001-00034.
Der volle Inhalt der QuelleKim, Han-Soo, Dimitrios Degiannis, Jana Raskova und Karel Raska. „Cyclosporine A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: Correlation with proliferative responses“. Clinical Immunology and Immunopathology 60, Nr. 1 (Juli 1991): 27–39. http://dx.doi.org/10.1016/0090-1229(91)90109-n.
Der volle Inhalt der Quellevan der Merwe, P. Anton, Dale L. Bodian, Susan Daenke, Peter Linsley und Simon J. Davis. „CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics“. Journal of Experimental Medicine 185, Nr. 3 (03.02.1997): 393–404. http://dx.doi.org/10.1084/jem.185.3.393.
Der volle Inhalt der QuelleCaruso, C., G. Candore, D. Cigna, S. Tripi, G. Di Gaetano, G. Migneco, G. Montalto, I. Ruggieri und A. Notarbartolo. „Serum Levels of Soluble IL-2R, CD4 and CD8 in Chronic Active HCV Positive Hepatitis“. Mediators of Inflammation 3, Nr. 3 (1994): 185–87. http://dx.doi.org/10.1155/s0962935194000256.
Der volle Inhalt der QuelleMartens, A., RAJ Janssen, DTh Sleijfer, AA Heijn, NH Mulder, TH The und L. de Leij. „Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response“. British Journal of Cancer 67, Nr. 5 (Mai 1993): 1118–21. http://dx.doi.org/10.1038/bjc.1993.205.
Der volle Inhalt der Quelle